SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD FEB 05
MCX SILVER MAR 05
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD FEB 05
MCX SILVER MAR 05
MCX CRUDEOIL FEB 19
MCX NATURALGAS JAN 25
USD/INR
EUR/INR
GBP/INR
JPY/INR

Closing Bell: Sensex, Nifty slip from record highs to end lower; banks, metal stocks drag

Global Markets: Asia shares pare losses as China economy rebounds

Oil prices extend gains after US inventory drop

Wrapping 2020 with a subtle depreciation- What’s on the cards for the Rupee in 2021?

Earnings

Dabur Q1 net profit falls 5.9% to Rs 341.8 crore; volumes decline 9.7%

Updated : July 31, 2020 10:21 AM IST

Dabur's domestic volume during Q1FY21 declined at 9.7 percent versus expectations of 14-15 percent decline.

The quarter saw our new products record sales of over Rs 100 crore.

Dabur India reported a net 5.9 percent fall in net profit at Rs 341.8 crore for the quarter ended June 2020 crore as against Rs 363.1 crore in the same period last year. The profit beat CNBC-TV18 analysts' poll estimates of Rs 330 crore.

Revenue during the quarter declined 12.9 percent to Rs 1,980 crore from Rs 2,273.3 crore, YoY. Revenue was higher than estimates of Rs 1,975 crore.

Dabur's domestic volume in Q1FY21 fell at 9.7 percent versus expectations of 14-15 percent decline.

EBITDA fell 8.9 percent to Rs 416.6 crore from Rs 457.6 crore while EBITDA margin improved by 93 bps to 21.04 percent from 20.1 percent, year on year.

"Despite a challenging April, the quarter saw a nearly 7-fold growth in demand for Dabur Chyawanprash and an over 60% surge in demand for Dabur Honey. Dabur has significantly ramped up capacity with production now at near-normal levels and the business poised to deliver growth for the rest of the year," said Mohit Malhotra, Chief Executive Officer, Dabur India.

Dabur Chyawanprash reported a growth of over 694 percent during the quarter, while Dabur Honitus grew by over 80 percent while Dabur Honey ended Q1 2020-21 with a growth of over 60 percent.

The quarter saw Dabur introduce a record number of new products and variants anchored on the consumer need for Health, Immunity and Hygiene.

The quarter saw our new products record sales of over Rs 100 crore.

The OTC Healthcare Business ended the quarter with a 34 percent growth while the Ayurvedic Ethicals business was up 11 percent. The Toothpaste Business, on the back of continued demand for our flagship Dabur Red Paste, ended the quarter with a nearly 3 percent growth, it added.

You May Also Like

Home First Finance Company IPO fully subscribed on day 1

Home First Finance Company IPO fully subscribed on day 1

Bajaj Auto Q3 profit rises 23% YoY to Rs 1,556.3 cr; reports highest ever turnover

Bajaj Auto Q3 profit rises 23% YoY to Rs 1,556.3 cr; reports highest ever turnover

Expect Brent crude to be around $51-52 per barrel in 1st half of 2021, says Wood Mackenzie’s Sushant Gupta

Expect Brent crude to be around $51-52 per barrel in 1st half of 2021, says Wood Mackenzie’s Sushant Gupta

Trending on CNBC-TV18

Live TV

recommended for you